Reactive oxygen species and not lipoxygenase products are required for mouse B-lymphocyte activation and differentiation
- 31 July 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (7), 533-546
- https://doi.org/10.1016/0192-0561(94)90105-8
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytesClinical Immunology and Immunopathology, 1992
- Leukotriene B4 in the immune systemInternational Journal of Immunopharmacology, 1992
- [1] Role of free radicals and catalytic metal ions in human disease: An overviewMethods in Enzymology, 1990
- Eicosanoid metabolism by lymphocytes: Do all human nucleated cells generate eicosanoids?Pharmacological Research, 1989
- Eicosanoids and rheumatology: Inflammatory and vascular aspectsProstaglandins, Leukotrienes & Essential Fatty Acids, 1989
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- The generation of oxygen radicals: A positive signal for lymphocyte activationCellular Immunology, 1988
- Frequency of B lymphocytes responsive to anti-immunoglobulin.The Journal of Experimental Medicine, 1982
- Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytesBiochemical and Biophysical Research Communications, 1981
- Use of an in vitro Antibody-Producing System for Recognizing Potentially Immunosuppressive CompoundsInternational Archives of Allergy and Immunology, 1978